Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs MYE Q1 2026 Earnings Strong Earnings Beat as Profitability Surges Past Estimates OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline KAI Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Positively WPC Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Decline ASTL Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Resilience